Simplex Trading’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Simplex Trading’s Portfolio EVFM Stock Details EVFM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-546	Closed	–	–	11162
2022 Q3	$0	Sell	546 -35,957	-99%	-$33.2K	﹤0.01%	11524
2022 Q2	$41K	Buy	36,503 +35,970	+6,749%	+$59.3K	﹤0.01%	6753
2022 Q1	$2K	Hold	533	–	–	﹤0.01%	10002
2021 Q4	$3K	Hold	533	–	–	﹤0.01%	9935
2021 Q3	$8K	Hold	533	–	–	﹤0.01%	9089
2021 Q2	$9K	Sell	533 -346	-39%	-$6.56K	﹤0.01%	9194
2021 Q1	$23K	Buy	879 +155	+21%	+$7.04K	﹤0.01%	7367
2020 Q4	$0	Sell	724 -425	-37%	-$15.4K	﹤0.01%	9374
2020 Q3	$0	Sell	1,149 -403	-26%	-$17.5K	﹤0.01%	8819
2020 Q2	$0	Buy	+1,552	New	+$105K	﹤0.01%	8670

Simplex Trading's EVFM Position: Q4 2022 in Review

Simplex Trading sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q4 2022, closing a stake of 546 shares.

Simplex Trading first reported a position in EVFM in Q2 2020 and held it in 10 quarters. The position peaked at $41K in Q2 2022. 0 funds tracked by Wall St. Rank hold EVFM as of Q4 2022.

Simplex Trading reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Simplex Trading sold 546 Evofem Biosciences, Inc. Common Stock shares in Q4 2022.
Simplex Trading first reported a position in Evofem Biosciences, Inc. Common Stock in Q2 2020 and held it in 10 quarters.
Simplex Trading's Evofem Biosciences, Inc. Common Stock position peaked at $41K in Q2 2022.
0 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q4 2022.

Based on Simplex Trading's 13F filing for Q4 2022, filed 2 Feb 2023.